Generation of two induced pluripotent stem cell lines from hereditary hemorrhagic telangiectasia patients harboring ACVRL1 mutations.

Two induced pluripotent stem cell lines from hereditary hemorrhagic telangiectasia patients with ACVRL1 mutations were successfully generated and characterized.

• Why it matters: HHT is a vascular disorder linked to ACVRL1 mutations, but understanding its cellular mechanisms requires relevant human models. This work addresses the gap by providing patient-derived cell lines for research.
• What they did: Researchers generated two iPSC lines from HHT patients carrying heterozygous ACVRL1 mutations, confirming their morphology, marker expression, genomic stability, and differentiation capacity.
• The result: These iPSC lines serve as valuable resources for studying ACVRL1 haploinsufficiency and may facilitate mechanistic and therapeutic investigations into HHT vascular pathology.